Tag Innovation and tech transfer
Go Big Read marries art and science with “Radioactive”
Lauren Redniss was first drawn to Marie and Pierre Curie because of their beautiful love story. But the Pulitzer Prize-winning illustrator found much more as she researched, wrote and illustrated her book “Radioactive: Marie and Pierre Curie, A Tale of Love and Fallout,” this year’s selection for Go Big Read, UW–Madison's common reading program. Read More
Breakthrough device to debut at National Eye Institute’s 40th anniversary kickoff event
A portable vision device that provides blind individuals sensory input similar to vision will be presented at the 40th anniversary celebration for the National Eye Institute, part of the National Institutes of Health, on Friday, April 3. Read More
Course builds community of biomedical entrepreneurs
A new multidisciplinary course at the University of Wisconsin–Madison is preparing entrepreneurial graduate students to bring biomedical innovations to the patients who need them. Read More
All NIH human embryonic stem cell registry lines now deposited at NSCB
The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry. Read More
VistaGen, WARF sign license agreement for human embryonic stem cell technology
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools. Read More
WiCell Research Institute launches new stem cell bank
The WiCell Research Institute, a private, not-for-profit supporting organization to the University of Wisconsin–Madison, is launching its own stem cell bank to distribute cell lines beyond the 21 lines eligible for federal funding and distribution through the National Stem Cell Bank (NSCB). Read More
New ‘urban research park’ offers jolt of electricity to Madison high-tech startups
After three decades of almost exponential commercial growth on Madison's west side, the University Research Park (URP) will pursue an opportunity to sink roots downtown with an innovative "urban research park" targeting high-technology entrepreneurs. Read More
Airless tire project may prove a lifesaver in military combat
An ambitious startup company in Wausau is working on a project to develop tires that can withstand extreme punishment, even those meted out in military combat zones. Read More
Green highways: Research targets environmentally friendly asphalts
For those hoping to create a greener world, our country's millions of miles of asphalt roads may seem like an odd place to seek solutions. Yet, it's precisely because asphalt is so common that we have much to gain from making it more eco-friendly, says University of Wisconsin–Madison civil engineering professor Hussain Bahia. Read More
WARF licenses influenza vaccine technology to FluGen
The Wisconsin Alumni Research Foundation and FluGen have signed license agreements for a technology that has the potential to significantly improve the way influenza vaccines are manufactured. Read More
Invitrogen, WARF sign license agreement for human embryonic stem cells
Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools. Read More
Roche NimbleGen CEO Stan Rose to speak on exit strategies for start-up companies
Stan Rose, president and CEO of Roche NimbleGen, a manufacturer of gene chips for pharmaceutical research, will speak about successful exit strategies for start-up companies on Monday, April 28 at 5 p.m. at the Fluno Center, 601 University Avenue. The event is free and open to the public as part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation (WARF). Read More
TomoTherapy’s Mackie to speak on faculty entrepreneurship
Thomas Rockwell Mackie, co-founder, chairman of the board and director of research at TomoTherapy, will speak on faculty entrepreneurship on Wednesday, April 2, beginning at 5 p.m. The event, part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation, is free and open to the public. Read More
California company licenses WARF stem cell technology
BioTime, Inc. (OTCBB: BTIM) has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for 173 patents and patent applications relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin–Madison. Read More
WARF announces new hires and promotions
The Wisconsin Alumni Research Foundation (WARF) has announced promotions for Michael E. Falk and Emily Bauer, and the hires of a communications director, Janet L. Kelly, and two licensing professionals, Craig Heim for start-up companies, and Mark Stoveken for pharmaceutical licensing. Read More
Basic research robust in face of more university patenting
A UW–Madison study of more than 1,800 U.S. life scientists found that, despite an explosion in academic patenting in recent years, most life science professors still do research the "old-fashioned" way: they win federal grants, publish results in scientific journals, and graduate Ph.D. students. Read More
State seeds stem-cell company based on UW–Madison research
Governor Jim Doyle today (May 14) gave a $1 million boost to a University of Wisconsin–Madison spin-off company during a visit to the campus lab that gave birth to its technology. Read More